rxstat › Drug prices › Mometasone Furoate Glycopyrronium Indacaterol

Mometasone Furoate Glycopyrronium Indacaterol (Enerzair Breezhaler) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Mometasone Furoate Glycopyrronium Indacaterol 50 mcg / 150 mcg / 160 mcg capsule costs about $3.43 per capsule on public drug plan price lists across 5 provinces, before the pharmacy's dispensing fee.

Mometasone Furoate Glycopyrronium Indacaterol has no current shortage reported in Canada. No active reports are on file.

Price by province

Strength and formABSKONNBNS
50 mcg / 150 mcg / 160 mcg Capsuleper capsule$3.43$3.43$3.43$3.43$3.43
Plan coverageCoveredSpecial approvalCoveredSpecial approvalSpecial approval

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 1 product
  • Enerzair Breezhaler 50 mcg / 150 mcg / 160 mcg Capsule · VLP
    DIN 02501244 · $3.43/capsule · Covered
Saskatchewan: 1 product
  • Enerzair Breezhaler 50 mcg / 150 mcg / 160 mcg Capsule · VAL
    DIN 02501244 · $3.43/capsule · Special approval
Ontario: 1 product
  • Enerzair Breezhaler 50 mcg / 150 mcg / 160 mcg Capsule · Novartis Pharma Canada Inc.
    DIN 02501244 · $3.43/capsule · Covered
New Brunswick: 1 product
  • Enerzair Breezhaler 50 mcg / 150 mcg / 160 mcg Capsule · NVR
    DIN 02501244 · $3.43/capsule · Special approval
Nova Scotia: 1 product
  • Enerzair Breezhaler 50 mcg / 150 mcg / 160 mcg Capsule · VAL
    DIN 02501244 · $3.43/capsule · Special approval

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 1
Reports on file
1

Shortage history

2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

Resolved
ENERZAIR BREEZHALER
160MCG 50MCG 150MCG · CAPSULE · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02501244 · ended May 21, 2024 · Delay in shipping of the drug.

What's happening

There are no active shortage reports for Mometasone Furoate Glycopyrronium Indacaterol.

Recent changes

Common questions

How much does Mometasone Furoate Glycopyrronium Indacaterol cost in Canada?

Mometasone Furoate Glycopyrronium Indacaterol 50 mcg / 150 mcg / 160 mcg capsule costs about $3.43 per capsule on public drug plan price lists across 5 provinces, before the pharmacy's dispensing fee.

Is Mometasone Furoate Glycopyrronium Indacaterol covered by provincial drug plans?

On the public plans' own lists: Alberta: covered; Saskatchewan: special approval; Ontario: covered; New Brunswick: special approval; Nova Scotia: special approval. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Mometasone Furoate Glycopyrronium Indacaterol be back in stock in Canada?

Mometasone Furoate Glycopyrronium Indacaterol has no active shortage; supply is normal per Health Canada reports.

Why is Mometasone Furoate Glycopyrronium Indacaterol in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.